Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

IDEXX Laboratories Q3 Adj. EPS $3.22 Beats $3.13 Estimate, Sales $1.105B Beat $1.073B Estimate

Author: Benzinga Newsdesk | November 03, 2025 06:31am
IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $3.22 per share which beat the analyst consensus estimate of $3.13 by 2.84 percent. This is a 15.41 percent increase over earnings of $2.79 per share from the same period last year. The company reported quarterly sales of $1.105 billion which beat the analyst consensus estimate of $1.073 billion by 3.01 percent. This is a 13.27 percent increase over sales of $975.543 million the same period last year.

Posted In: IDXX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist